Skip to content

Validation of 2 methods of continuous cardiac output measurement during exercise in patients with chronic heart failure: LiDCO and Physioflow

Validation of 2 methods of continuous cardiac output measurement during exercise in patients with chronic heart failure: LiDCO and Physioflow - CO validation study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON30666
Enrollment
10
Registered
2007-03-13
Start date
2007-03-13
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic heart failure left ventricular dysfunction

Interventions

None listed

Sponsors

Máxima Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Stable chronic heart failure due to myocardial infarction or dilating cardiomyopathy NYHA II-III left ventricular ejection fraction

Exclusion criteria

Exclusion criteria: Exclusion criteria: Factors that potentially influence the accuracy of the measurements: - Lithium use - Weight 200 mmHg , diastolic > 100 mmHg) - Prosthetic valve - Atrial or ventricular thrombus - Thrombo-embolic events in the past - Positive Allen*s test

Design outcomes

Primary

MeasureTime frame
Difference and agreement between lithium dilution and direct Fickk method at rest. Difference and agreement between PulseCO, Physioflow and the direct Fick method.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)